Lixiu Yu

ORCID: 0000-0001-6780-0502
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Wnt/β-catenin signaling in development and cancer
  • Ovarian cancer diagnosis and treatment
  • Eicosanoids and Hypertension Pharmacology
  • Medicinal Plant Pharmacodynamics Research
  • Phytoestrogen effects and research
  • Renin-Angiotensin System Studies
  • Pulmonary Hypertension Research and Treatments
  • Natural product bioactivities and synthesis
  • Ginseng Biological Effects and Applications
  • Kruppel-like factors research
  • Cancer Cells and Metastasis
  • Caveolin-1 and cellular processes
  • Traditional Chinese Medicine Analysis
  • Biomarkers in Disease Mechanisms
  • Cytokine Signaling Pathways and Interactions
  • Cancer, Lipids, and Metabolism

Union Hospital
2015-2018

Huazhong University of Science and Technology
2015-2018

Signal transducers and activators of transcription (STAT) family are critical factors, which have been proved as prognostic predictors for a number cancers. However, the roles STAT in breast cancer patients remain dispute. In present study, we mined 'Kaplan-Meier plotter' (KM plotter) online database to explore mRNA expression including overall survival (OS), progression-free (PFS), well post-progression (PPS). The results suggest high all individual STATs, except STAT1 STAT2, significantly...

10.1042/bsr20171175 article EN Bioscience Reports 2018-01-12

Decreased epithelial cadherin (E-cadherin) expression is hypothesized to be related poor prognosis of ovarian cancer, but the predictive value still inconsistent. We conducted an updated meta-analysis with a total 16 studies enrolling 1720 patients estimate prognostic decreased E-cadherin in cancer. Reduced was significantly associated overall survival (HR = 1.74, 95% CI: 1.40-2.17) and progression-free 1.45, 1.12-1.86) large heterogeneity for survival. In addition, we found that correlated...

10.18632/oncotarget.20885 article EN Oncotarget 2017-09-14
Coming Soon ...